Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen in GHD and Turner Syndrome
NCT00256126Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- May 2005
- Primary completion
- Sep 2007
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 13
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), Turner syndrome (TS), sponsored by Merck KGaA. Started May 2005; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)Turner syndrome (TS)
Beyond the preview
Go deeper on NCT00256126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256126.